newsfilter
← Latest News
GlobeNewswire·

Pluri Shortlisted for CDMO of the Year Award by Advanced Therapies Awards 2025

HAIFA, Israel, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (NASDAQ:PLUR) (TASE:PLUR) ("Pluri" or the "Company"), a leading biotechnology company leveraging its proprietary platform for cell-based solutions